Free Trial

Enfusion (ENFN) SEC Filings & 10K Form

Enfusion logo
$10.63 +0.16 (+1.53%)
(As of 12/20/2024 05:16 PM ET)

Recent Enfusion SEC Filings

DateFilerForm TypeView
12/20/2024
2:57 PM
Enfusion (Subject)
Herring Bradley (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/03/2024
3:44 PM
Enfusion (Subject)
Pawar Neal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
3:52 PM
Enfusion (Issuer)
Pawar Neal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
3:21 PM
Enfusion (Subject)
Pawar Neal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2024
2:33 PM
Enfusion (Subject)
Pawar Neal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/04/2024
3:15 PM
Enfusion (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
7:15 AM
Enfusion (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
6:13 PM
Enfusion (Subject)
Malherbe Investments LLC (Filed by)
Form SC 13G/A
10/25/2024
3:30 PM
Enfusion (Subject)
LRA Ventures, LLC (Filed by)
Form SC 13G/A
10/24/2024
3:15 PM
Campobasso Matthew (Reporting)
Enfusion (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
2:43 PM
Campobasso Matthew (Reporting)
Enfusion (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
3:15 PM
Bastone Bronwen (Reporting)
Enfusion (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
2:16 PM
Bastone Bronwen (Reporting)
Enfusion (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/06/2024
2:32 PM
BROWN CAPITAL MANAGEMENT LLC (Filed by)
Enfusion (Subject)
Form SC 13G/A
08/06/2024
3:16 PM
Enfusion (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2024
6:45 AM
Enfusion (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
5:38 PM
Bastone Bronwen (Reporting)
Enfusion (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
5:39 PM
Campobasso Matthew (Reporting)
Enfusion (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
5:40 PM
Enfusion (Issuer)
Gutowski Valeria (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:19 PM
Bastone Bronwen (Reporting)
Enfusion (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2024
2:45 PM
Campobasso Matthew (Reporting)
Enfusion (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2024
2:50 PM
Bastone Bronwen (Reporting)
Enfusion (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
8:08 PM
Enfusion (Issuer)
LEIBOWITZ LAWRENCE E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
8:10 PM
DeRose Kathleen (Reporting)
Enfusion (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
8:11 PM
Enfusion (Issuer)
Hauser Jan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
8:12 PM
Enfusion (Issuer)
Spellacy Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
8:14 PM
Enfusion (Issuer)
Somers Deirdre (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
2:16 PM
Enfusion (Subject)
Somers Deirdre (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/22/2024
2:36 PM
Bastone Bronwen (Reporting)
Enfusion (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
3:29 PM
Bastone Bronwen (Reporting)
Enfusion (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2024
6:45 AM
Enfusion (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
3:25 PM
Enfusion (Filer)
Form ARS
04/26/2024
3:20 PM
Enfusion (Filer)
Form DEFA14A
04/26/2024
3:15 PM
Enfusion (Filer)
Form DEF 14A
03/19/2024
5:30 AM
Enfusion (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2024
3:16 PM
Enfusion (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2024
7:45 AM
Enfusion (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2024
7:45 AM
Enfusion (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2024
4:15 PM
CSL Tech Holdings LLC (Reporting)
Enfusion (Issuer)
Movchan Oleg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:24 PM
Enfusion (Issuer)
Gutowski Valeria (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:25 PM
Enfusion (Issuer)
Pawar Neal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

03/05/2024
7:26 PM
CSL Tech Holdings LLC (Reporting)
Enfusion (Issuer)
Movchan Oleg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:20 PM
Bastone Bronwen (Reporting)
Enfusion (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:21 PM
Campobasso Matthew (Reporting)
Enfusion (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:23 PM
Enfusion (Issuer)
Herring Bradley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:35 PM
Campobasso Matthew (Reporting)
Enfusion (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:32 PM
Enfusion (Issuer)
Gutowski Valeria (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
2:22 PM
Campobasso Matthew (Reporting)
Enfusion (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/16/2024
3:46 PM
Enfusion (Subject)
Groman Dan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/15/2024
3:46 PM
Enfusion (Subject)
Groman Dan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
5:08 AM
Enfusion (Subject)
Werner Capital LLC (Filed by)
Form SC 13G/A
02/07/2024
7:00 AM
Enfusion (Subject)
LRA Ventures, LLC (Filed by)
Form SC 13G/A
01/24/2024
3:20 PM
Enfusion (Subject)
Groman Dan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/23/2024
3:31 PM
Enfusion (Subject)
Groman Dan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2024
3:40 PM
Enfusion (Subject)
Groman Dan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/19/2024
4:25 PM
Enfusion (Issuer)
Gutowski Valeria (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/18/2024
7:20 AM
Enfusion (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/12/2024
6:00 PM
Enfusion (Issuer)
Somers Deirdre (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
7:00 PM
Bastone Bronwen (Reporting)
Enfusion (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
7:01 PM
Enfusion (Issuer)
Herring Bradley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
7:02 PM
Campobasso Matthew (Reporting)
Enfusion (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
7:02 PM
CSL Tech Holdings LLC (Reporting)
Enfusion (Issuer)
Movchan Oleg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
2:15 PM
Enfusion (Subject)
Somers Deirdre (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:27 PM
Enfusion (Subject)
Movchan Oleg (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:28 PM
Enfusion (Subject)
Herring Bradley (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:13 PM
Bastone Bronwen (Reporting)
Enfusion (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:15 PM
Enfusion (Subject)
Groman Dan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:23 PM
Campobasso Matthew (Reporting)
Enfusion (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
8:18 AM
Enfusion (Subject)
Herring Bradley (Reporting)
Form 144/A
01/08/2024
3:27 PM
Enfusion (Subject)
Groman Dan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:35 PM
Enfusion (Subject)
Movchan Oleg (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:22 PM
Campobasso Matthew (Reporting)
Enfusion (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:22 PM
Bastone Bronwen (Reporting)
Enfusion (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:24 PM
Enfusion (Subject)
Herring Bradley (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:ENFN) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners